Role of Patient-Reported Outcome Measures in the Inpatient Setting-Reply

Affiliations

Comment

Ryan D Nipp et al. JAMA Oncol. 2022.

. 2022 Sep 1;8(9):1358-1359.

doi: 10.1001/jamaoncol.2022.2555.

¹ Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital & Harvard Medical School, Boston.

No abstract available

Comment on

Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer: A Randomized Clinical Trial.
Nipp RD, Horick NK, Qian CL, Knight HP, Kaslow-Zieve ER, Azoba CC, Elyze M, Landay SL, Kay PS, Ryan DP, Jackson VA, Greer JA, El-Jawahri A, Temel JS. Nipp RD, et al. JAMA Oncol. 2022 Apr 1;8(4):571-578. doi: 10.1001/jamaoncol.2021.7643. JAMA Oncol. 2022. PMID: 35142814 Free PMC article. Clinical Trial.
Role of Patient-Reported Outcome Measures in the Inpatient Setting.
Al-Rashdan A. Al-Rashdan A. JAMA Oncol. 2022 Sep 1;8(9):1358. doi: 10.1001/jamaoncol.2022.2552. JAMA Oncol. 2022. PMID: 35834265 No abstract available.